Clinical trial
Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With St-segment Elevation Myocardial Infarction (Copernican)
NCT06353594 is registered in ClinicalTrials.gov with Hospital Universitario La Fe as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With St-segment Elevation Myocardial Infarction (Copernican)
- Lead sponsor
- Hospital Universitario La Fe
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 11, 2024
- Completion date
- September 30, 2035
- Enrollment
- 1,272 (estimated)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.